Glaritus (insulin glargine biosimilar)
/ Wockhardt
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 08, 2019
Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients
(clinicaltrials.gov)
- P3; N=0; Withdrawn; Sponsor: Wockhardt; N=500 ➔ 0
Enrollment change
1 to 1
Of
1
Go to page
1